Cardiovascular Disease (Cardiology) · Pittsburgh, PA
NPI
1366417099
Since 2006
Specialty
Cardiovascular Disease (Cardiology)
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
200 Lothrop St, Wing 5b Puh
Pittsburgh, PA, 15213
Phone (412) 647-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
414 services
Medicare patients, 2024
181
Average age 71
Drug cost, 2024
$7.4M
3,923 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Mathier was code 99232 (hospital e&m - subsequent), 118 times for 32 patients. In total Michael Mathier billed 414 services in 19 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 118 | 32 | $58.87 | $6,946 |
| 99214 Office E&M - Established | Facility | 70 | 64 | $63.49 | $4,444 |
| 99214 Office E&M - Established | Office | 36 | 34 | $88.57 | $3,188 |
| 99291 Critical Care E&M | Facility | 22 | 12 | $161.28 | $3,548 |
| 99239 Hospital Discharge Management | Facility | 17 | 15 | $81.30 | $1,382 |
| 99442 Telephone Services | Office | 15 | 12 | $46.62 | $699 |
| 99204 Office E&M - New | Facility | 14 | 14 | $100.79 | $1,411 |
By year: 2022 $30K for 468 services; 2023 $33K for 455 services; 2024 $29K for 414 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Mathier prescribed most often to Medicare patients was Spironolactone, with 321 prescriptions and refills. In total Michael Mathier wrote 3,923 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 321 | 828 | 105 | $3,306 |
| Tadalafil Generic | 272 | 296 | 34 | $302K |
| Ambrisentan Generic | 241 | 249 | 28 | $686K |
| Metoprolol Succinate Generic | 237 | 611 | 77 | $3,578 |
| Jardiance Empagliflozin | 221 | 526 | 74 | $294K |
| Entresto Sacubitril/Valsartan | 208 | 478 | 58 | $302K |
| Furosemide Generic | 184 | 474 | 72 | $1,628 |
| Carvedilol Generic | 183 | 482 | 57 | $2,907 |
| Bumetanide Generic | 174 | 394 | 51 | $11K |
| Eliquis Apixaban | 141 | 268 | 36 | $152K |
| Atorvastatin Calcium Generic | 130 | 337 | 41 | $1,656 |
| Sildenafil Citrate Generic | 111 | 149 | 16 | $46K |
| Losartan Potassium Generic | 103 | 246 | 31 | $1,112 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 100 | 254 | 26 | $739 |
| Uptravi Selexipag | 93 | 93 | 12 | $2.0M |
Brand drugs: 1,041 claims; generic drugs: 2,882 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Mathier $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.